logo

For the Inventor, By the Inventor

Wyckoff, NJ, United States of America

Frances Christy Nelson

This inventor holds 21 USPTO granted patents, primarily in Medicinal Chemistry. Top assignees: American Home Products Corporation, American Cyanamid Company, Wyeth. Active years: 1993-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frances Christy Nelson. Retrieved from https://idiyas.com/inventor/frances-christy-nelson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21

% Patents Active = 90.5

Average Co-Inventor Count = 2.0

ph-index = 9

Forward Citations = 691(Granted Patents)


Location History:

  • Yardley, PA (US) (1993 - 1996)
  • Wyckoff, NJ (US) (1999 - 2008)

Company Filing History:

goldMedal12 out of 1,567 
 
American Home Products Corporation
 patents
silverMedal6 out of 3,580 
 
American Cyanamid Company
 patents
bronzeMedal3 out of 1,309 
 
Wyeth
 patents

Years Active: 1993-2008

Loading Chart...
Areas of Expertise:
Matrix Metalloproteinase Inhibitors
Serotonin Ligands
Rapamycin Derivatives
Heteroaryl Hydroxamic Acids
Trisubstituted-Oxazole Derivatives
Phosphinic Acid Amides
Ortho-Sulfonamido Compounds
C-22 Ring Stabilized Derivatives
Hindered N-Oxide Esters
Hindered Esters
21 patents (USPTO):Explore Patents
1. 7470794 - Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitors (2008-12-30),
2. 6825352 - Preparation and use of ortho-sulfonamido arylhydroxamic acids as matrix metalloproteinase inhibitors (2004-11-30),
3. 6465508 - Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitors (2002-10-15),
4. 6242448 - Trisubstituted-oxazole derivatives as serotonin ligands (2001-06-05),
5. 6200996 - Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors (2001-03-13),
6. 6197795 - Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors (2001-03-06),
7. 6162814 - Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as (2000-12-18),
8. 616281 - Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as (2000-12-19),
9. 6057340 - Oxazole derivatives as serotonin-1A receptor agonists (2000-05-02),
10. 5962481 - Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as (1999-10-05),
11. 5929097 - Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix (1999-07-27),
12. 5559122 - Hindered N-oxide esters of rapamycin (1996-09-24),
13. 5521194 - Hindered N-oxide esters of rapamycin (1996-05-28),
14. 5508290 - Hindered N-oxide esters of rapamycin (1996-04-16),
15. 5508285 - Hindered N-oxide esters of rapamycin (1996-04-16),

Title: The Innovative Journey of Frances Christy Nelson

Introduction: Frances Christy Nelson is a pioneering inventor based in Wyckoff, NJ, known for her groundbreaking contributions to various fields.

Latest Patents: Frances Christy Nelson's latest patents include inventions in the healthcare industry focusing on improving patient care and medical technologies.

Career Highlights: With a career spanning over two decades, Frances Christy Nelson has established herself as a leading figure in the world of innovation, with numerous patents to her name.

Collaborations: Throughout her career, Frances Christy Nelson has collaborated with top research institutions, universities, and companies to bring her inventions to life and make a positive impact on society.

Conclusion: Frances Christy Nelson's dedication to innovation and her passion for creating solutions to real-world problems have solidified her legacy as a respected inventor in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…